24 May 2019
Genus plc
Director/PDMR Shareholding
Genus plc (LSE: GNS) announces that Dr. Nate Zwald, Chief Operating Officer, Genus ABS Dairy and member of the Genus Executive Leadership Team ('GELT'), sold 2,261 ordinary shares in the Company on 23 May 2019 on the London Stock Exchange at a price of 2,688 pence per share.
The below notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail of the number of ordinary shares sold.
For further information please contact:
Genus:
Vaughn Walton, Interim Deputy Company Secretary Tel: +44 (0)1256 347100
Table A - GELT Private Share Sale
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
|
a. |
Name |
Dr. Nate Zwald |
||||
|
2. |
Reason for the notification |
|||||
|
a. |
Position/status |
Chief Operating Officer, Genus ABS Dairy |
||||
|
b. |
Initial notification /Amendment
|
Initial notification |
||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
|
a. |
Name |
Genus plc |
||||
|
b. |
LEI |
54930022EOITNKSIGH56 |
||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
|
a. |
Description of the Financial instrument, type of instrument Identification code |
Ordinary shares of 10p each
GB0002074580 |
||||
|
b. |
Nature of the transaction |
Sale of 2,261 ordinary shares. |
||||
|
c. |
Price(s) and volume(s) |
|
||||
|
d. |
Aggregated information · Aggregated volume · Price
|
|
||||
|
e. |
Date of the transaction |
2019-05-23 |
||||
|
f. |
Place of the transaction |
London Stock Exchange, Main Market (XLON) |
||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
